Activities, Bill Numbers and Titles
|
|
Client: Pharmaceutical Research and Manufacturers of America Corporation
|
Total amount paid by client; lobbyist is unable to report compensation at activity level: $1,884.59
|
Senate Bill
|
2520
|
An Act relative to pharmaceutical access, costs and transparency
|
Oppose
|
$0.00
|
N/A
|
Executive
|
Center for Health Information and Analysis (CHIA)
|
Discussed prescription drug pricing
|
Neutral
|
$0.00
|
N/A
|
Senate Bill
|
612
|
An Act relative to promoting healthcare access and affordability for patients
|
Support
|
$0.00
|
N/A
|
Senate Bill
|
749
|
An Act relative to pharmaceutical access, costs and transparency
|
Oppose
|
$0.00
|
N/A
|
House Bill
|
4600
|
An Act making appropriations for the fiscal year 2025 for the maintenance of the departments, boards, commissions, institutions, and certain activities of the commonwealth, for interest, sinking fund, and serial bond requirements, and for certain permanent improvements
|
Neutral
|
$0.00
|
N/A
|
House Bill
|
934
|
An Act to enact the pharmacy benefit manager compensation reform
|
Support
|
$0.00
|
N/A
|
House Bill
|
978
|
An Act relative to promoting healthcare access and affordability for patients
|
Support
|
$0.00
|
N/A
|
House Bill
|
1215
|
An Act relative to pharmacy benefit managers
|
Support
|
$0.00
|
N/A
|
| | |
Total amount
|
$0.00
| |
|
|
|
Meals, Travel, and Entertainment Expenses
|
No meals, travel, or entertainment expenses were filed for this disclosure reporting period. |
|
|
Additional Expenses
|
No additional expenses were filed for this disclosure reporting period. |
|
|
Campaign Contributions
|
No campaign contributions were filed for this disclosure reporting period. |
|